Improved progression free survival for patients with diabetes and locally advanced non-small cell lung cancer (NSCLC) using metformin during concurrent chemoradiotherapy

Krista C. J. Wink*, Jose S. A. Belderbos, Edith M. T. Dieleman, Maddalena Rossi, Coen R. N. Rasch, Ronald A. M. Damhuis, Ruud M. A. Houben, Esther G. C. Troost

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

Original languageEnglish
Pages (from-to)453-459
JournalRadiotherapy and Oncology
Volume118
Issue number3
DOIs
Publication statusPublished - Mar 2016

Keywords

  • Metformin
  • NSCLC
  • Diabetes
  • Chemotherapy
  • Radiotherapy

Cite this